Advanced Oncotherapy has announced the promotion of Nicolas Serandour, chief operating officer and chief financial officer, to chief executive. Current chief executive Dr Michael Sinclair will retain his role as executive chairman. Commenting, Dr Sinclair said: ‘At this critical stage in our company’s development it is appropriate that the roles of chairman and chief executive…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
